TABLE 2.
Number (and %) of participants tested with a detectable antigen-specific IgA ASC response, 7 days after the second and third vaccine dose
Post 2nd injection |
Post 3rd injection |
|||||
---|---|---|---|---|---|---|
PorA | FetA | OMV | PorA | FetA | OMV | |
25 μg | NT | NT | NT | 3/20 (15%) | 0/20 (0%) | 15/20 (75%) |
50 μg | 8/23 (35%) | 2/23 (9%) | 17/23 (74%) | 6/19 (32%) | 0/19 (0%) | 16/19 (84%) |